Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities

Xiao-Ming Wang; Wing Yan Yik; Peilin Zhang; Wange Lu; Ning Huang; Bo Ram Kim; Shibata, Darryl; Zitting, Madison; Chow, Robert H.; Moser, Ann B.; Steinberg, Steven J.; Hacia, Joseph G.
August 2015
Stem Cell Research & Therapy;Aug2015, Vol. 6 Issue 1, p1
Academic Journal
Introduction: Zellweger spectrum disorder (PBD-ZSD) is a disease continuum caused by mutations in a subset of PEX genes required for normal peroxisome assembly and function. They highlight the importance of peroxisomes in the development and functions of the central nervous system, liver, and other organs. To date, the underlying bases for the cell-type specificity of disease are not fully elucidated. Methods: Primary skin fibroblasts from seven PBD-ZSD patients with biallelic PEX1, PEX10, PEX12, or PEX26 mutations and three healthy donors were transduced with retroviral vectors expressing Yamanaka reprogramming factors. Candidate induced pluripotent stem cells (iPSCs) were subject to global gene expression, DNA methylation, copy number variation, genotyping, in vitro differentiation and teratoma formation assays. Confirmed iPSCs were differentiated into neural progenitor cells (NPCs), neurons, oligodendrocyte precursor cells (OPCs), and hepatocyte-like cell cultures with peroxisome assembly evaluated by microscopy. Saturated very long chain fatty acid (sVLCFA) and plasmalogen levels were determined in primary fibroblasts and their derivatives. Results: iPSCs were derived from seven PBD-ZSD patient-derived fibroblasts with mild to severe peroxisome assembly defects. Although patient and control skin fibroblasts had similar gene expression profiles, genes related to mitochondrial functions and organelle cross-talk were differentially expressed among corresponding iPSCs. Mitochondrial DNA levels were consistent among patient and control fibroblasts, but varied among all iPSCs. Relative to matching controls, sVLCFA levels were elevated in patient-derived fibroblasts, reduced in patient-derived iPSCs, and not significantly different in patient-derived NPCs. All cell types derived from donors with biallelic null mutations in a PEX gene showed plasmalogen deficiencies. Reporter gene assays compatible with high content screening (HCS) indicated patient-derived OPC and hepatocyte-like cell cultures had impaired peroxisome assembly. Conclusions: Normal peroxisome activity levels are not required for cellular reprogramming of skin fibroblasts. Patient iPSC gene expression profiles were consistent with hypotheses highlighting the role of altered mitochondrial activities and organelle cross-talk in PBD-ZSD pathogenesis. sVLCFA abnormalities dramatically differed among patient cell types, similar to observations made in iPSC models of X-linked adrenoleukodystrophy. We propose that iPSCs could assist investigations into the cell type-specificity of peroxisomal activities, toxicology studies, and in HCS for targeted therapies for peroxisome-related disorders.


Related Articles

  • Gene Reprogramming Has Become Possible.  // USA Today Magazine;Oct2011, Vol. 140 Issue 2797, p7 

    The article focuses on a study by scientists from the Morganridge Institute for Research at the University of Wisconsin which shows that potentially cancer-causing mutations in induced pluripotent stem cells (IPSCs) do not exhibit substantial increases during gene reprogramming.

  • Drosophila Carrying Pex3 or Pex16 Mutations Are Models of Zellweger Syndrome That Reflect Its Symptoms Associated with the Absence of Peroxisomes. Nakayama, Minoru; Sato, Hiroyasu; Okuda, Takayuki; Fujisawa, Nao; Kono, Nozomu; Arai, Hiroyuki; Suzuki, Emiko; Umeda, Masato; Ishikawa, Hiroyuki O.; Matsuno, Kenji // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    The peroxisome biogenesis disorders (PBDs) are currently difficult-to-treat multiple-organ dysfunction disorders that result from the defective biogenesis of peroxisomes. Genes encoding Peroxins, which are required for peroxisome biogenesis or functions, are known causative genes of PBDs. The...

  • Zellweger syndrome and secondary mitochondrial myopathy. Salpietro, Vincenzo; Phadke, Rahul; Saggar, Anand; Hargreaves, Iain; Yates, Robert; Fokoloros, Christos; Mankad, Kshitij; Hertecant, Jozef; Ruggieri, Martino; McCormick, David; Kinali, Maria // European Journal of Pediatrics;Apr2015, Vol. 174 Issue 4, p557 

    Defects in peroxisomes such as those associated with Zellweger syndrome (ZS) can influence diverse intracellular metabolic pathways, including mitochondrial functioning. We report on an 8-month-old female infant and a 6-month-old female infant with typical clinical, radiological and laboratory...

  • Opportunities and challenges of pluripotent stem cell neurodegenerative disease models. Sandoe, Jackson; Eggan, Kevin // Nature Neuroscience;Jul2013, Vol. 16 Issue 7, p780 

    Human neurodegenerative disorders are among the most difficult to study. In particular, the inability to readily obtain the faulty cell types most relevant to these diseases has impeded progress for decades. Recent advances in pluripotent stem cell technology now grant access to substantial...

  • Stem Cell Mutations Explored. Luntz, Stephen // Australasian Science;Mar2012, Vol. 33 Issue 2, p5 

    The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.

  • Unexpected mutations put stem cell trial on hold. Coghlan, Andy // New Scientist;8/8/2015, Vol. 227 Issue 3033, p9 

    The article reports that a stem-cell trial using induced pluripotent stem cells has been halted after mutations were found in the cells of a participant, including a mutation that could carry a remote cancer risk, and mentions the trial turned skin cells into retinal cells to try and reverse...

  • The individuality of stem cells. Lander, Arthur D. // BMC Biology;2011, Vol. 9 Issue 1, p40 

    In this article the author comments on the uniqueness of stem cells. He states that stem cells are considered to be different from other cells because of properties like immortality, pluripotency and asymmetric division. However, such properties are not common in all stem cells and can be seen...

  • Neurogenic differentiation of amniotic fluid stem cells. Rosner, M.; Mikula, M.; Preitschopf, A.; Feichtinger, M.; Schipany, K.; Hengstschl√§ger, M. // Amino Acids;May2012, Vol. 42 Issue 5, p1591 

    In 2003, human amniotic fluid has been shown to contain stem cells expressing Oct-4, a marker for pluripotency. This finding initiated a rapidly growing and very promising new stem cell research field. Since then, amniotic fluid stem (AFS) cells have been demonstrated to harbour the potential to...

  • Phacomatosis Pigmentokeratotica Is a 'Pseudodidymosis'. Happle, Rudolf // Journal of Investigative Dermatology;Aug2013, Vol. 133 Issue 8, p1923 

    In phacomatosis pigmentokeratotica, papular nevus spilus coexists with nevus sebaceus. The disorder was thought to be a didymosis with early postzygotic recombination. In this issue, however, Groesser and co-workers provide a new concept. Both nevi originate from a single heterozygous HRAS...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics